Float Short %

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

0.01

EPS Last/This Y

1.31

EPS This/Next Y

0.38

Price

1.37

Target Price

3.44

Analyst Recom

2.47

Performance Q

15.97

Relative Volume

0.49

Beta

2.06

Ticker: EDIT

23 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	EDIT	1.32	0.10	0.01	41202
2025-04-15	EDIT	1.36	0.09	0.56	41160
2025-04-16	EDIT	1.265	0.10	0.07	41669
2025-04-17	EDIT	1.285	0.10	0.03	41845
2025-04-18	EDIT	1.28	0.10	0.03	41845
2025-04-21	EDIT	1.34	0.09	0.00	39820
2025-04-22	EDIT	1.56	0.09	0.01	40447
2025-04-23	EDIT	1.55	0.09	0.00	40274
2025-04-24	EDIT	1.61	0.09	0.01	40328
2025-04-25	EDIT	1.54	0.088940822521288	0.008686210640608	40538
2025-04-28	EDIT	1.58	0.088539026017345	0.069411764705882	40793
2025-04-29	EDIT	1.54	0.09	0.22	41215
2025-04-30	EDIT	1.64	0.09	0.14	41190
2025-05-01	EDIT	1.62	0.09	0.06	42396
2025-05-02	EDIT	1.63	0.09	0.01	42697
2025-05-05	EDIT	1.53	0.09	0.03	43852
2025-05-06	EDIT	1.32	0.09	0.04	44048
2025-05-07	EDIT	1.31	0.09	0.39	44701
2025-05-08	EDIT	1.38	0.09	0.04	45009
2025-05-09	EDIT	1.45	0.09	0.02	45233
2025-05-12	EDIT	1.53	0.09	0.01	45783
2025-05-13	EDIT	1.495	0.09	0.01	48061
2025-05-14	EDIT	1.375	0.08	0.05	48089
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	EDIT	1.32	23.0	-	-1.53
2025-04-15	EDIT	1.35	23.0	-	-1.53
2025-04-16	EDIT	1.26	23.0	-	-1.53
2025-04-17	EDIT	1.28	23.0	-	-1.53
2025-04-18	EDIT	1.28	23.0	-	-1.53
2025-04-21	EDIT	1.34	23.0	-	-1.53
2025-04-22	EDIT	1.56	23.0	-	-1.53
2025-04-23	EDIT	1.56	23.0	-	-1.53
2025-04-24	EDIT	1.61	23.0	-	-1.53
2025-04-25	EDIT	1.54	23.0	-	-1.53
2025-04-28	EDIT	1.58	23.0	-	-1.53
2025-04-29	EDIT	1.55	23.0	-	-1.53
2025-04-30	EDIT	1.65	23.0	-	-1.53
2025-05-01	EDIT	1.62	23.0	-	-1.53
2025-05-02	EDIT	1.64	23.0	-	-1.57
2025-05-05	EDIT	1.54	21.9	-	-1.57
2025-05-06	EDIT	1.33	21.9	-	-1.57
2025-05-07	EDIT	1.33	21.9	-	-1.57
2025-05-08	EDIT	1.38	21.9	-	-1.57
2025-05-09	EDIT	1.44	21.9	-	-1.57
2025-05-12	EDIT	1.54	21.9	-	-1.57
2025-05-13	EDIT	1.50	21.9	-	-1.57
2025-05-14	EDIT	1.37	21.9	-	-1.57
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	EDIT	-3.27	-7.42	15.30
2025-04-15	EDIT	-3.21	-7.42	15.30
2025-04-16	EDIT	-3.21	-7.42	15.30
2025-04-17	EDIT	-3.21	-7.42	15.30
2025-04-18	EDIT	-3.21	-7.42	15.30
2025-04-21	EDIT	-3.21	-7.49	15.30
2025-04-22	EDIT	-3.21	-7.49	15.30
2025-04-23	EDIT	-3.21	-7.49	15.30
2025-04-24	EDIT	-3.21	-7.49	15.30
2025-04-25	EDIT	-3.21	-7.49	15.30
2025-04-28	EDIT	-3.21	-7.67	15.27
2025-04-29	EDIT	-3.21	-7.67	15.27
2025-04-30	EDIT	-3.21	-7.67	15.27
2025-05-01	EDIT	-3.21	-7.67	15.27
2025-05-02	EDIT	-3.21	-7.67	15.27
2025-05-05	EDIT	-3.21	-8.67	15.27
2025-05-06	EDIT	-3.21	-8.67	15.27
2025-05-07	EDIT	-3.21	-8.67	15.27
2025-05-08	EDIT	-3.21	-8.67	15.27
2025-05-09	EDIT	-3.21	-8.67	15.27
2025-05-12	EDIT	-3.21	-7.62	14.00
2025-05-13	EDIT	-3.21	-7.62	14.00
2025-05-14	EDIT	-3.21	-7.62	14.00
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

-0.43

Avg. EPS Est. Current Quarter

-0.58

Avg. EPS Est. Next Quarter

-0.42

Insider Transactions

-3.21

Institutional Transactions

-7.62

Beta

2.06

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.6

Max Drawdown 5-Year %

-98.9

Target Price

3.44

P/E

Forward P/E

PEG

P/S

3.22

P/B

1.85

P/Free Cash Flow

EPS

-3.04

Average EPS Est. Cur. Y

-1.57

EPS Next Y. (Est.)

-1.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-701.06

Relative Volume

0.49

Return on Equity vs Sector %

-426.1

Return on Equity vs Industry %

-409.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

Editas Medicine, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 246

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

stock quote shares EDIT – Editas Medicine, Inc. Stock Price stock today

news today EDIT – Editas Medicine, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EDIT – Editas Medicine, Inc. yahoo finance google finance

stock history EDIT – Editas Medicine, Inc. invest stock market

stock prices EDIT premarket after hours

ticker EDIT fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EDIT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y